|
The utility of chemotherapy after immunotherapy failure in metastatic melanoma: A multicenter case series. |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Roche |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Roche |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche |
Consulting or Advisory Role - Amgen; Merck Serono; MSD |
Research Funding - 4SC (Inst); Amgen (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Immunocore (Inst); Novartis (Inst); Philogen (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - MSD |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche |
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche |
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre |
|
|
Travel, Accommodations, Expenses - Roche |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sun Pharma; Takeda |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sun Pharma; Takeda |
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Roche (Inst) |
|
|
Consulting or Advisory Role - Compugen |
Travel, Accommodations, Expenses - Genentech/Roche; Tesaro |
|
Elizabeth Iannotti Buchbinder |
Employment - Biodesix (I); Smith & Nephew (I) |
Consulting or Advisory Role - Array BioPharma; Checkmate Pharmaceuticals |
Research Funding - Bristol-Myers Squibb; Checkmate Pharmaceuticals; Merck |
|
|
Consulting or Advisory Role - Amgen; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Genmab; Incyte; MedImmune; Merck Serono; Merck Sharp & Dohme; Newlink Genetics; Novartis; Pierre Fabre; Roche/Genentech; Syndax |
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech (Inst) |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - MSD; NanoString Technologies |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Array Biopharma; Bristol-Myers Squibb; Genoptix; Incyte; Merck; Novartis |
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Incyte |
Patents, Royalties, Other Intellectual Property - Intellectual property and patents pending surrounding use of MHC-II and response to immune therapy |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; MSD |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD |
|
|
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche |
Speakers' Bureau - Amgen; Bristol-Myers Squibb; MSD; Roche |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; Roche |
Travel, Accommodations, Expenses - Bristol-Myers Squibb |